(R)-2-((R)-1-(6-amino-9H-purin-9-yl)-2-oxoethoxy)-3-oxopropyl trihydrogen diphosphate

ID: ALA4277262

Chembl Id: CHEMBL4277262

Cas Number: 64060-84-0

PubChem CID: 5491933

Max Phase: Preclinical

Molecular Formula: C10H13N5O10P2

Molecular Weight: 425.19

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1ncn2[C@@H](C=O)O[C@@H](C=O)COP(=O)(O)OP(=O)(O)O

Standard InChI:  InChI=1S/C10H13N5O10P2/c11-9-8-10(13-4-12-9)15(5-14-8)7(2-17)24-6(1-16)3-23-27(21,22)25-26(18,19)20/h1-2,4-7H,3H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t6-,7+/m0/s1

Standard InChI Key:  NVPIJHRHNNQNDN-NKWVEPMBSA-N

Alternative Forms

  1. Parent:

    ALA4277262

    ADP-Dialdehyde

Associated Targets(Human)

ENPP1 Tchem Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (635 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ENPP3 Tchem Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.19Molecular Weight (Monoisotopic): 425.0138AlogP: -1.08#Rotatable Bonds: 10
Polar Surface Area: 226.28Molecular Species: ACIDHBA: 12HBD: 4
#RO5 Violations: 1HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 1.77CX Basic pKa: 4.89CX LogP: -4.51CX LogD: -7.37
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.26Np Likeness Score: 0.59

References

1. Lee SY, Müller CE..  (2017)  Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.,  (5): [PMID:30108800] [10.1039/C7MD00015D]
2. Lee SY, Namasivayam V, Boshta NM, Perotti A, Mirza S, Bua S, Supuran CT, Müller CE..  (2021)  Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.,  12  (7.0): [PMID:34355184] [10.1039/D1MD00117E]

Source